Patent details

Basic Information

Publication number:

EP1353693

PCT Application Number:

PCT/US/2002/001130

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP027031277

PCT Publication Number:

WO/2002/056912

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMBINATION CONTAINING A 4-QUINAZOLINEAMINE AND PACLITAXEL, CARBOPLATIN OR VINORELBINE FOR THE TREATMENT OF CANCER

French Title of Invention:

COMBINAISON PHARMACEUTIQUE CONTENANT DE L'AMINO-4 QUINAZOLINE ET PACLITAXEL, CARBOPLATIN OR VINORELBINE POUR LE TRAITEMENT DU CANCER

German Title of Invention:

PHARMAZEUTISCHE MISCHUNG GEGEN KREBS, DIE EIN 4-CHINAZOLINAMIN IN KOMBINATION MIT PACLITAXEL, CARBOPLATIN OR VINORELBINE ENTHÄLT

SPC Number:

Dates

Filing date:

14/01/2002

Grant date:

16/03/2005

EP Publication Date:

16/03/2005

PCT Publication Date:

25/07/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/10/2003

EP B1 Publication Date:

16/03/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/01/2006

Expiration date:

14/01/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/01/2002

 

 

Name:

GLAXO GROUP LIMITED

Address:

Glaxo Wellcome House Berkeley Avenue, Greenford, Middlesex UB6 ONN, United Kingdom (GB)

Inventor

1

Name:

LACKEY Karen, Elizabeth, GlaxoSmithKline

Address:

United States (US)

2

Name:

SPECTOR Neil, GlaxoSmithKline

Address:

United States (US)

3

Name:

WOOD Edgar, Raymond III, GlaxoSmithKline

Address:

United States (US)

4

Name:

XIA Wenle, GlaxoSmithKline

Address:

United States (US)

Priority

Priority Number:

262402 P

Priority Date:

16/01/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 45/06;

Filing date	Document type	Number of pages